FindTrial
Sign In

Anticraving drug utilization in alcohol use disorder

Anticraving drug utilization and risk of relapse in patients with Alcohol Use Disorder - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/11/077246
Enrollment
106
Registered
2024-11-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F109- Alcohol use, unspecified

Interventions

Intervention1: Nil: Nil

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants of either gender, aged above 18 years. Participants diagnosed with AUD presented with or without comorbidities taking anti-craving medications for a minimum duration of 1 month after admission

Exclusion criteria

Exclusion criteria: Participants or caretakers of patients with AUD who are unwilling to participate in the study. Participants/ caretakers who are not responding well to the queries Participants who quit treatment against medical advice

Design outcomes

Primary

MeasureTime frame
The pattern of drinking, extent of anti-craving drug utilisation and craving dynamicity will be studied. Timepoint: 0, 1 month—

Secondary

MeasureTime frame
The risk of relapse in patients taking anti-craving drugs will be studied.Timepoint: 1 month—

Countries

India

Contacts

Public ContactDr Shishir Kumar

Nitte Gulabi Shetty Memorial Institute of Pharmaceutical Sciences

junojoel@nitte.edu.in9480470727

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026